The Riverside Company has sold UK healthcare business OrthoD to specialist investor Apposite Capital.
OrthoD manufactures and distributes medical products and implants for joint reconstruction and sports medicine, surgical products and infection control applications. Its offering includes bone cement mixing and fixation devices.
Healthcare specialist Apposite has introduced Oern Stuge, a 25-year veteran of the medtech sector, as non-executive chairman. The firm intends to increase the company’s export channels and further commercialise its sport medicine products.
Riverside backed the Gloucestershire-based business in March 2008. During its hold it made bolt-ons in France and Germany.
Partner Martin Scott, principal Tommy Seddon, associate Julius Hugelshofer and senior operating partner Fabio Pesiri worked on the deal for Riverside.
William Blair, KPMG, LEK and Jones Day advised Riverside. Alvarez & Marsal, Charles Russell Speechlys, Lambourn Associates and Wyvern Partners advised Apposite.
Source: Real Deals. April 2018. [https://realdeals.eu.com/news/2018/04/03/riverside-orthod-apposite-capital/].